-The Hindu A 2012 WHO study ranks India third — behind Myanmar and Bangladesh — among countries that fail to provide health cover to people. A 2011 study reported in The Lancet on ‘Healthcare and equity’ confirms this: every year, at least 39 million people here fall into poverty due to private out-of-pocket health expenditure. A vast majority of Indians do not have access to healthcare or essential drugs. By the...
More »SEARCH RESULT
Total Matching Records found : 501
Anybody ill here and seen a doctor yet? -Krishna D Rao
-The Hindu The Planning Commission’s draft 12th Plan for health has attracted much debate and controversy. Critics have been quick to direct their attention at two issues in it — the proposed increase in government health spending from one per cent to 1.58 per cent of GDP, and the “managed care model.” The spending increase was rightly felt to be grossly inadequate to move India towards achieving universal health care. The...
More »Cancer, HIV patients suffer as morphine supplies are hobbled by excessive regulation
-The Economic Times MUMBAI: India, the world's largest exporter of morphine sulphate, has very little of the drug to offer its terminally ill patients suffering from cancer and HIV. The supply of morphine, a narcotic pain reliever used for treating pain, is severely constrained in local hospitals and retail stores due to stringent laws that prevent and hinder companies from making and transporting the final product. Morphine sulphate is a byproduct of...
More »I-T dept to cancel ‘charitable’ status of Ramdev trust, withdraw exemptions -Ritu Sarin
-The Indian Express The Income-Tax department is set to cancel the registration of yoga guru Baba Ramdev’s trust as a charitable organisation and withdraw all exemptions provided to it. This follows a final order passed on August 24 by the Income-Tax (exemption) unit in the case of his principal charitable organisation, the Patanjali Yogpeeth Trust, for the year 2009-10, after a scrutiny revealed that it was involved in a host of...
More »CDSCO drafting new norms for financial compensation-Mahim Pratap Singh
-The Hindu In the year 2011, 438 people died due to Serious Adverse Events (SAEs) during medicine trials in India, but pharmaceutical companies provided financial compensation in only 16 such cases. The total amount paid in compensation in all the 16 cases adds up to Rs. 34.88 lakh, with the highest amount being Rs. 5 lakh, and the lowest being Rs. 50,000. This makes 2011 only the second year, for which data are...
More »
